| Hearing way too much from customers at the Lancome counter
We've all encountered an audience whore. You know exactly who I mean: the same insatiable, bleached-out single mom who haunts the aisles of every corner store, hanging on any opportunity to spill her guts to some unsuspecting passerby. You can find her in long lines at the grocery store or at your local PTO meeting amid a conglomeration of her cultish peers.
In my case, those audience whores tend to find me while I'm on the job. They're an inevitable blip on the screen, something you dodge around corners to escape but collide with twice as hard as a result. I would never doubt that the earth trembles with every movement of the past, but if you were to imagine humanity as this skin under which a myriad of stories lies latent, these people would be the acne -- oozing, inflamed with their own legends.
Medicis revenue climbs 45%
Despite new competition for Restylane, its star performer, Scottsdale drug maker and marketer Medicis boosted revenue 45 percent in the quarter that ended Sept. 30 compared with third-quarter 2006 numbers. The companys bottom line got a big boost from two relatively new acne products, Solodyn and Ziana, CEO Jonah Shacknai said Wednesday in a conference call with analysts. And wrinkle-filler Restylane continued to be a strong market leader even though Medicis rival Allergan launched a similar product earlier this year. Shacknai credited TV commercials and other direct-to-customer marketing with significantly boosting Restylane Web traffic and creating new business. The short-term future looks so good Shacknai upped annual earnings estimates to $1.22 from the $1.12 he predicted at the beginning of the year.
Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh The Benefits Of Physical ...
The changing of the season brings cooler weather, shorter days and more people heading to health clubs for a healthy dose of indoor exercise. While experts agree that exercise is one of the most beneficial activities a person can do to improve one's overall health, dermatologists want gym goers to be aware of the hidden dangers of exercise -- bothersome skin conditions that can be painful and inhibit further physical activity if left untreated.
Speaking today at the American Academy of Dermatology's (Academy) Skin Academy, dermatologist Brian B. Adams, MD, MPH, FAAD, associate professor of dermatology at the University of Cincinnati and director of dermatology at the Veterans Administration Medical Center, both in Cincinnati, Ohio, discussed the most common skin conditions to which people who engage in regular indoor exercise are susceptible and how to treat them.
Feeling Stressed? Dermatologists Can Help Manage the Effects of Stress on the Skin, Hair and Nails
Pending job cuts at the office. Back-to-back final exams. A messy divorce. An unexpected surgery. What do they all have in common? In a word – stress. While everyone knows that stress can take a toll on a person physically and psychologically, it also can lead to dermatologic problems, such as acne, brittle nails or even hair loss. .
Bradley Pharmaceuticals 2007 Third Quarter Results
FAIRFIELD, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, (Nachrichten) Inc. announced today that it has filed with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. Third Quarter of 2007 -- Launched ADOXA(R) 150mg capsules. -- Paid outstanding principal balance of $62.4 million under old credit facility on August 3, 2007 with existing cash and cash equivalents, concurrently with entering into a new credit facility and wrote-off deferred financing costs of $3.3 million related to old facility. -- On October 29, 2007, the Company entered into a definitive merger agreement with Nycomed US Inc. Bradley reported that net sales for the quarter ended September 30, 2007 were approximately $33.6 million, a decrease of $1.6 million, or 5%, from net sales of $35.2 million for the quarter ended September 30, 2006.
L'Oreal's Fourth International Symposium on Ethnic Hair and Skin Spotlights Breakthrough Treatments for Key ...
The fourth international symposium on ethnic hair and skin, a gathering of respected scientific thought leaders, will convene November 9-11, 2007 in Miami, Fla. The symposium is sponsored by the L'Oreal Institute for Ethnic Hair and Skin Research in partnership with Howard University College of Medicine Department of Dermatology. .
Skincare Knowledge: Avoiding Excoriation After Skin Care Procedures
Skincare-News.com warns readers about excoriation, a painful condition caused when skin has changed and is sensitive to aggressive treatments. Sacramento, CA (PRWEB) November 4, 2007 -- Excoriation -- erosion or destruction of the skin by mechanical means, which appears in the form of a scratch or abrasion. It is commonly seen in other skin disorders causing itching, dry skin, dermatitis and possibly scabies. Skincare-News.com's latest article, "Exfoliation, Extractions and Excoriation" is especially important for anyone who regularly gets waxes, peels or microdermabrasion. Also discussed in the article are exfoliation and extractions, two other important skin care words to know.
http://www.skincare-news.com/articles.php?ArtID=460 According to the article, skin changes quickly, so lifestyle changes such as new medications, recent pregnancy or retinol products should always be discussed with an esthetician or dermatologist.
Questions raised about drug being studied for MS
A group of American scientists has warned other researchers that an acne drug being tested as a possible treatment for a variety of neurodegenerative diseases - including in Canada for multiple sclerosis - may actually cause harm. The scientists reported that in a clinical trial of patients with amyotrophic lateral sclerosis or Lou Gehrig's disease, those who received the drug minocycline declined more rapidly than those who received a placebo. Their report, published Thursday in the journal Lancet Neurology, comes just a week after the Multiple Sclerosis Society of Canada announced it was funding a multi-centre Phase 3 trial to look at whether the inexpensive and off-patent minocycline can slow the progression of MS when treatment is commenced in the earliest stages of the disease.
|
